Erratum: Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells.

IF 5.3 2区医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL

Molecular Therapy Oncolytics Pub Date : 2023-09-21 DOI:10.1016/j.omto.2023.08.002

Chiara F Magnani, Renier Myburgh, Silvan Brunn, Morgane Chambovey, Marianna Ponzo, Laura Volta, Francesco Manfredi, Christian Pellegrino, Steve Pascolo, Csaba Miskey, Nicolás Sandoval-Villegas, Zoltán Ivics, Judith A Shizuru, Dario Neri, Markus G Manz

引用次数: 0

Abstract

[This corrects the article DOI: 10.1016/j.omto.2023.07.003.].

查看原文本刊更多论文

纠错:含有安全开关的抗cd117 CAR - T细胞根除人类急性髓性白血病和造血干细胞。

[这更正了文章DOI: 10.1016/ j.m to.2023.07.003.]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Molecular Therapy Oncolytics Medicine-Oncology

CiteScore

10.90

自引率

3.50%

发文量

152

审稿时长

6 weeks

期刊介绍： Molecular Therapy — Oncolytics is an international, online-only, open access journal focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer.